RxDoctor Payments Data

Susan Shafii, MD

Vascular Surgery · Clearwater, FLNPI 1154570851

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.2%), consulting fees and grants — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Silk Road Medical, Inc. at 47.7% of the total. Reporting peaked in 2020 at $4,673 and has fallen 74.5% since, to $1,194 in 2025.

$13,455in general payments, 2019–2025

Across 116 payments — averaging $115.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$6K
  • Boston Scientific$3K
  • Endologix LLC$1K
  • Cook Medical LLC$900
  • Bolton Medical Inc$447
  • W. L. Gore & Associates, Inc.$353
  • plus $800 from 15 others
$39,149in research payments, 2019–2025

Across 18 payments — averaging $2174.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Silk Road Medical, Inc.$33K
  • Boston Scientific$6K

What the payments were for

  • Consulting fees$5,93144%
  • Grants$620%
  • Travel & lodging$360%
  • Food & beverage$7,42755%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,455 in reported general payments places this provider in the 70th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$153,687
Medicare patients
369
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate107$934
Rosuvastatin Calcium51$794
Cilostazol19$789
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$286
Atorvastatin Calcium32$228
Gabapentin11$125
Tramadol Hcl83$111

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →